NIH clinical trial of investigational vaccine for COVID-19 begins in Seattle
Sharon Brooks
Monday, March 16, 2020
Body
A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research